Tumor cell metaphases of classical Hodgkin's lymphoma (cHL) characteristically display highly rearranged karyotypes with chromosome numbers in the hyperploid range and marked intraclonal variability. The causes of this cytogenetic pattern remain largely unknown. An unusual type of chromosomal abnormality coined as segmental chromosomal aberration (SCA) has been recurrently observed in HL cell lines and was suggested to be associated with ribosomal DNA (rDNA) rearrangements. Moreover, centrosome abnormalities provoking deficient chromosome segregation have been reported in many solid tumors and also in cHL cell lines. Whether SCA, rDNA rearrangements or centrosome abnormalities also occur in primary cHL is not yet known. Thus, we performed extensive molecular cytogenetic and immunohistological studies in two cHL cases. Both cases presented SCA associated with genomic gains of the REL and JAK2 loci, respectively. The SCA involving JAK2 was associated with rDNA rearrangements. The absolute centrosome size of HRS cells in both cases was significantly larger than in non-HRS cells, but the relative centrosome size of HRS cells corrected for nuclear size was in the same range as that of the non-neoplastic cells. These findings demonstrate that the various mechanisms associated with chromosomal instability warrant a more detailed characterization in cHL.
Introduction
Classical Hodgkin's lymphoma (cHL) is characterized by low proportions of tumor cells, the so-called Hodgkin and ReedSternberg (HRS) cells, immersed in a nontumoral cell infiltrate. Conventional chromosome analyses in cHL frequently fail due to the scarcity of the clonal HRS cells, that lead either to the complete lack of metaphases or the presence of normal karyotypes derived from the non-neoplastic bystander cells. In cases with clonally altered metaphases, hyperploid karyotypes with a high load of unresolved chromosomal abnormalities have been commonly described. [1] [2] [3] [4] Therefore, and in contrast to many other B-cell lymphomas, characteristic chromosomal abnormalities have not yet been discovered by classical cytogenetics. 4, 5 Recently, multicolor karyotyping of cHLderived cell lines and single-cell molecular cytogenetic studies in cHL cases have yielded initial insights into the recurrent chromosomal changes in the HRS cells. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] By comparative genomic hybridization (CGH) from microdissected HRS cells, recurrent gains including amplifications have been described in 2p, 9p and 12q in cHL. 11 By interphase cytogenetic techniques, these changes have been shown to increase the REL/BCL11A, JAK2 and MDM2 gene copy numbers, respectively. 8, [10] [11] [12] Interphase cytogenetic studies have also revealed a marked intratumor variability in the number of certain chromosomes or gene loci investigated among the HRS cells of a given sample. These findings suggest some kind of ongoing chromosomal instability in cHL. 6, 12 Similarly, cytogenetic studies and multicolor karyotyping of HL-derived cell lines demonstrated a huge amount of chromosomal changes with marked variation among the metaphases of an individual line. 9, 13, 14 Interestingly, multiple segmental chromosomal aberrations (SCAs) were detected in the cHL cell lines HDLM-2, KM-H2, L428 and L1236. These SCAs involved mostly telomeric sequences like 4p16, 8q24, 9p24 and 12p13, but also intrachromosomal sequences like 2p13-16. 13 The term SCA implies that multiple copies of a certain chromosomal segment are translocated or inserted into different parts of the genome, finally resulting in an increased gene dosage (eg JAK2 or REL/BCL11A). Thus, SCAs represent a mechanism of gene amplification, different from the classical double minutes or homogeneously staining regions (hsr), that generate multiple structurally abnormal chromosomes. The same phenomenon has been previously described in rare cases of secondary leukemias as well as in primary lymphomas and leukemias with advanced disease stage, and is termed 'segmental jumping translocation'. 16, 17 Nevertheless, a 'jumping translocation', as originally defined by Lejeune and coworkers, 18 is a rare chromosomal event in which a certain break leads to translocation of a given chromosomal region to different chromosome partners in the coexisting cell lines of an individual sample. As outlined by Cuthbert et al, 19 the term 'segmental jumping translocation' does not appropriately describe SCA because the latter phenomenon does not necessarily occur in different cell lines of a sample, but rather within the very same metaphase as clonal chromosomal change.
The causes of the intriguing chromosomal complexity and ongoing instability in cHL are largely unknown. Based on the association of some SCA with ribosomal DNA (rDNA) sequences in the cHL cell line HDLM-2, MacLeod and collaborators 9 suggested that complex chromosomal rearrangements of rDNA loci might drive SCA formation. Moreover, several lines of experimental evidence have proposed a link between chromosomal instability and aberrations of the centrosome. [20] [21] [22] [23] The centrosome is a discrete cellular domain composed of a pair of centrioles embedded in a matrix of proteins referred to as pericentriolar material (PCM). The centrosome is directly involved in the organization of the microtubules in the cell, and therefore plays a fundamental role in organizing both the cytoskeleton and mitotic spindle. During mitosis, chromosomes become attached to the spindle and each set of chromosomes is then segregated to daughter cells with high fidelity. 23 It has been hypothesized that numerical or structural centrosome alterations lead to the formation of monopolar or multipolar spindles which, in turn, provoke abnormal chromosome segregation. Recent studies suggest centrosome abnormalities to be common events not only in solid tumors 20, 21 but also in myeloid and lymphoid leukemias, as well as in non-Hodgkin's lymphomas. 22, 24 Regarding cHL, only analyses of the HL cell lines KM-H2 and L428 have been reported so far, and these lines were shown to bear centrosome abnormalities. 20 Considering the outstanding status of cHL among hematological malignancies with regard to its marked chromosomal complexity and instability, we investigated here two cases of cHL addressing the following questions: Are SCAs an epiphenomenon of cHL cell lines or do they occur in cHL cases as well? If so, are rDNA sequences associated with SCA in cHL? Do centrosome aberrations occur in cHL?
Materials and methods

Cases
Two cases of cHL and nodular sclerosis subtype were selected, based on the availability of suitable metaphase spreads for conventional and molecular cytogenetic analyses, as well as tissue sections for immunofluorescent and immunohistochemical analyses (Table 1 ).
Karyotyping and fluorescence in situ hybridization (FISH)
Cell culturing and harvesting as well as R-banding analysis were performed as described elsewhere. 25 For FISH, probes for REL/ BCL11A, JAK2, 12,13 rDNA (PAC 1174A5), PLK1 (BACs RP11-184F14 and CTD-2385L22), STK15 (BACs RP11-380D15 and RP5-1167H4), as well as for the centromere of chromosomes 9 (Vysis, Downers Grove, USA), 16 (Vysis) and 20 (plasmid pZ20), were applied. Probe preparation and FISH followed the recently published protocols. 26 Slides were evaluated with a Zeiss Axioskop 2 fluorescence microscope (Gö ttingen, Germany) equipped with appropriate filter sets (AHF, Tü bingen, Germany).
Immunohistochemistry
Immunohistochemical studies for the c-Rel protein using the antiserum 265 were performed as previously described. 15 
Double immunofluorescence
A polyclonal antiserum (3115) to pericentrin 2 (kendrin) was raised by immunizing rabbits with the peptide AGRTK-LAHFRQRKTKGD derived from the N-terminus of this centrosomal protein. The specificity of antiserum 3115 was confirmed by competition experiments (Knippschild et al, unpublished observations). For immunofluorescence, deparaffinized sections were pretreated by high-pressure cooking, and incubated with the rabbit polyclonal antibody 3115 in combination with a mouse monoclonal antibody to CD30 (Clone Ber-H2, DakoCytomation, Hamburg, Germany). Detection of pericentrin 2 (kendrin) and CD30 was performed with Cy3-conjugated donkey anti-rabbit and FITC-conjugated goat anti-mouse antisera, respectively (both from Jackson Immunoresearch/Dianova, Hamburg, Germany). The nuclei were counterstained with DAPI. Table 1 Results from conventional and molecular cytogenetic analyses in two patients with cHL 74B79o4n4,X,+del(X)(p11p22),Y,der(1)t(1;1) (p32;q10)del(1)(p13p22)hsr(1)(q10),der(1) t(1;15)(q12;q11),del(1)(q24),der(2)t(1;2) (q10;p16)hsr(1)(q10),add(2)(p13)hsr(2)(p13), ?i(2)(p10),add(3)(q27)hsr(3)(q27),À4,der(5) t(5;7)(p15;q11),add(5)(q14),À6,i(6)(p10),+7, add(7)(q21),À8,À8,À8,À9,À9,À10,der(10)t(10;?13) (p14B15;q12),À11,+12,add(12)(q21),dup(12) (q23q24),À13,À13,À13,À14,À14,À15,À15,À16,À16, der(17)t(1;17)(q10;p11),+21,add(21)(p13), add(21)(q22),À22,À22,À22,+mar [cp4] 72B75o3n4,XX,+der(X)t(X;?8)(p11;p12),-Y, del(1)(p21),+2,+2,add(3)(p21),der(3)t(1;3) (q21;q27),+4,ins(4;?)(q13;?),del(6)(q1?5q2?4), +7,del(7)(p21),-8,add(8)(p11),+9,dic(9;12) (p13;q24)ins(9;?)(p13;?),add(9)(p23), der(9)ins(9;?)(q13;?)t(9;9)(p13;q34),+10,del(10) (q22q25B26),der(12)t(9;12)(p12;q24) ins(12;?)(q24;?), -13,add (13) The quotient between the number of signals for REL/BCL11A and CEP2, JAK2 and CEP9, STK15 and CEP20, and PLK1 and CEP16 was calculated as a means to estimate the amplification ratio.
Centrosome measurements
In all, 25 CD30-positive HRS cells and 50 CD30-negative nonmalignant cells were analyzed in each case. Digital imaging capturing of these cells and accurate measurements of the centrosome area were performed by using the ISIS software (MetaSystems, Altlussheim, Germany). By immunofluorescence, the size of the captured structures varies depending on the integration time (IT) and focal plane. Therefore, the IT was fixed to 1.00 s for all image acquisitions and only centrosomes on focus were measured. Areas were determined in pixels and automatically transformed by the software to mm 2 (taking into account the use of an objective with Â 63 magnification).
Statistical analysis
By applying a significance level of 0.05 and a power of 0.80, measurements of a minimum of 15 cells per cell population (HRS vs non-HRS cells) were necessary to allow the detection of a difference at least two times the centrosome area. The nonparametric Mann-Whitney U-test was applied to objectively compare the centrosome size in HRS and non-HRS cells from each case, using the SPSS v11.0 statistical package (Erkrath, Germany).
Results and discussion
We report two cHL cases in which conventional chromosome analyses rendered a few, but high-quality, metaphase spreads. A complex hyperploid clone typical for HRS cells was observed in four of 18 metaphases of case 1 ( Figure 1a) and four of 19 metaphases of case 2. Karyotypes are described in Table 1 . Interphase FISH revealed amplification of the REL/BCL11A loci at 2p13-16 in case 1 (Figure 1b) and amplification of the JAK2 locus at 9p24 in case 2 (Table 1) . No evidence for genomic gains or chromosomal translocations of the JAK2 locus in case 1 and the REL/BCL11A loci in case 2 was found (Table 1) . In line with our recent observation of nuclear c-Rel protein accumulation in cHL cases with genomic amplification of the REL locus, 15 HRS cells in case 1 intensively stained for c-Rel in the nucleus and cytoplasm (Figure 1c) , whereas most HRS cells for case 2 completely lacked c-Rel staining and only few cells showed a faint cytoplasmic staining (data not shown).
Do SCAs occur in cHL?
In order to unmask whether SCAs lead to the amplification of the REL/BCL11A and JAK2 sequences, FISH was performed on previously R-banded metaphase spreads. Multiple different derivative chromosomes displayed hybridization signals for REL/BCL11A in case 1 ( Figure 1a ) and for JAK2 in case 2 ( Figure  1d, e) . Thus, the pattern of gene amplification was consistent with SCA in both cases, but with distinct features: case 1 showed multiple homogeneously staining regions (hsr) along with single or low copy insertions of REL/BCL11A into different parts of the genome. This indicates that different mechanisms of gene amplification (eg SCA and hsr) can occur simultaneously in the same cell. Case 2 lacked evidence for a hsr, but harbored multiple translocations of JAK2 to various derivative chromosomes (Table 1) .
Are rDNA sequences associated with SCA?
In order to study the hypothesis that SCA might be driven by rDNA aberrations, we rehybridized the same metaphases, as above, with an rDNA-specific probe. In case 1, hybridization signals were located at the p-arm of acrocentric chromosomes, which physiologically harbor the rDNA genes. There was no evidence for any colocalization of rDNA signals with REL/ BCL11A sequences. In contrast, case 2 displayed an amplification of the rDNA sequences with hybridization signals in various chromosomal regions. Remarkably, rDNA sequences colocalized in part with the SCA of 9p containing JAK2 (Figure 1f) . Thus, this case of cHL displays the very same phenomenon as the cHL cell line HDLM-2, where rDNA sequences were also shown to colocalize with JAK2. It has been described that rDNA and other repetitive DNA elements located at the short arm of acrocentric chromosomes might mediate the formation of Robertsonian translocations by homologous recombination of nonhomologous chromosomes. 27 Likewise, high densities of Alu repeats have been found at certain chromosomal translocation breakpoints and, thus, might be involved in the genesis of chromosomal aberrations. 28 Thus, the recurrent colocalization of rDNA and 9p24 sequences might suggest a role of rDNA in the generation of SCAs.
Do centrosome aberrations occur in cHL?
During the recent past, a correlation between centrosome abnormalities and chromosome instability has been repeatedly described in several types of solid and hematological tumors. [20] [21] [22] [23] As shown by interphase FISH, the two cases reported here are chromosomally unstable as the number of hybridization signals for the REL/BCL11A and JAK2 loci greatly vary along the different HRS cell nuclei (Table 1) . Thus, we investigated these two cases by immunofluorescence for possible centrosome changes. According to Pihan and collaborators, centrosome abnormalities are scored with regard to the number, size and shape of centrosomes, as well as with regard to pericentrin staining intensity and pattern. 20, 29 More than two centrosomes were not observed in the HRS cell from case 2 and only in a minority of HRS cells from case 1. Interestingly, tumor cells with only one centrosome were mononucleated, whereas the few HRS cells displaying multiple centrosomes were all multinucleated (Figure 1g ). The acquisition of multiple centrosomes might be associated with defects in the final step of cell division, that is, cytokinesis. 21 A defect in this mechanism has been reported to result in bi-or multinucleated cells, 30 which is a typical feature for the ReedSternberg cells in cHL.
For the evaluation of centrosome size, HRS cells (selected by virtue of their CD30 expression and characteristic morphology) were directly compared with the surrounding CD30-negative cells with regard to staining for the centrosome-specific protein pericentrin 2 (kendrin). In HRS cells from both cases, the median centrosome area was approximately three times larger than in the surrounding non-HRS cells (Figures 1h and 2a) . Based on these measurements, the HRS cells in the two cases studied have significantly larger centrosomes than the non-HRS cells. Nevertheless, it is possible that the large hyperploid HRS cells need more PCM to accomplish the same functions (eg to organize the cytoskeleton and mitotic spindle) as small non-HRS cells, and thus, require larger centrosomes. Therefore, we have corrected the centrosome size for nuclear size in both HRS and non-HRS cells. After this correction, the centrosome area in HRS cells was not any more significantly different from that in non-HRS cells (Figure 2b ). This issue raises the possibility that enlarged centrosomes observed in different tumor types might just reflect the increased tumor cell size or DNA content compared to their normal counterparts. Further studies are required to properly address this issue. A more detailed examination of the centrosome status would require not only the analysis of components of the PCM (eg pericentrin), but also to study the structure, size and number of centrioles.
The shape of centrosomes in the HRS cells from both cases was frequently similar to that in the non-HRS cells. No diffused cytoplasmatic pattern for pericentrin reported by Pihan et al 20 
Figure 1
Conventional cytogenetics by R-banding and subsequent FISH reveal the presence of multiple translocated segments leading to gene amplification of the REL/BCL11A or JAK2 loci. was observed in the two cases. However, as the antibodies against pericentin utilized in both studies are derived from different antisera, these results are not directly comparable.
Remarkably, the centrosome in HRS cells was frequently located next to nuclear concavities and colocalized with the typical perinuclear CD30 staining localized to the Golgi zone (Figure 1h ). In principle, this finding cannot be considered aberrant or tumor-related since in nonpolarized cells, like lymphoid cells, the Golgi apparatus is usually spherical and located around the centrosome. In fact, this spatial colocalization suggests a close functional relationship between the centrosome and the Golgi apparatus, as shown by recent reports (reviewed in Rios and Bornens 31 ). It has been described that genomic amplifications of the tyrosine kinase STK15 located at chromosome band 20q13 result in centrosome aberrations in several solid tumors. 32, 33 Similarly, overexpression of the Polo kinase gene PLK1 at 16p12 seems to promote centrosome amplification. 33 Genomic gains of 20q13 and 16p12 are found in 20 and 24% of cHL, respectively. 11 Thus, we applied FISH probes for STK15 and PLK1. Neither genomic amplifications of STK15 nor PLK1 were detected by FISH in the two cHL cases reported here and in an additional series of 15 cHL cases (Riemke et al, unpublished observations).
Conclusion
The present study provides extensive analyses of two cases of cHL with suitable metaphase spreads, aimed at shedding some initial light into the patterns and causes of the extreme cytogenetic complexity typical of this disease. We show that SCAs are not only an epiphenomenon of cHL cell lines, but also occur in primary cHL. Moreover, SCAs affecting 9p including the JAK2 locus might be recurrently associated with rDNA rearrangements. Centrosome aberrations as defined by Pihan and colleagues do also occur in cHL cases, and might be involved in the high chromosomal instability of HRS cells. Interestingly, the highly significant difference in the centrosome area between HRS and non-HRS cells in both cases turned out to be not statistically significant after correcting the centrosome size by nuclear size. The preliminary analyses and ideas presented herein should foster additional studies aimed at unravelling the causes and consequences of cytogenetic aberrations and chromosomal instability in HRS cells. Boxplot diagrams comparing the centrosome area in HRS and non-HRS cells before (a) and after correction of the centrosome area by nuclear area (b). P-values were calculated using the Mann-Whitney U-test. Quartiles 1 and 3 are shown in brackets below the median of each cell subgroup. Open circles represent simple outliers, whereas asterisks indicate extreme outliers.
